Codiak BioSciences, Inc(NASDAQ:CDAK) 
Codiak BioSciences, Inc., a clinical-stage biopharmaceutical company, focuses on developing exosome-based therapeutics for the treatment of oncology, neuro-oncology, neurology, neuromuscular diseases, infectious diseases, and other diseases. Its lead product candidates are exoSTING and exoIL-12, an ...
Website: https://www.codiakbio.com/
Founded: 2015
Full Time Employees: 105 (May 2021)
Sector: Healthcare
Industry: Biotechnology
Share this website to your friends
The information provided in this report is taken from www.sec.gov. While we have conducted our best efforts to ensure that the parsed data is accurate, we cannot guarantee its accuracy. Please use caution and understand that any consequences of its use are your own responsibility.
Day
Week
Month
Date 2023-03-20
P
O 0.37
H 0.50
L 0.36
C 0.48
V 729,703
10EMA 0.48
20EMA 0.48
60EMA 0.48
120EMA 0.48
250EMA 0.48